Background: Objective and reliable evaluation of UES opening during swallowing based on videofluoroscopy and pharyngeal manometry challenges dysphagia clinicians. The Functional Lumen Imaging Probe (FLIP) is a portable tool based on impedance planimetry originally designed to measure esophogastric junction compliance. It is hypothesised that FLIP can evaluate UES distensibility and can provide UES diameter and pressure measurements at rest, during swallowing and during voluntary manoeuvres. Methods: Eleven healthy adult subjects consented to FLIP evaluation. The probe was inserted trans-orally and the balloon positioned across the UES. Two twenty millilitre ramp distensions were completed. Changes in UES diameter and intra-balloon pressure were measured during dry and 5ml liquid swallows and during voluntary swallow postures and manoeuvres employed in clinical practice.
Background
Patterns and mechanisms of upper esophageal sphincter (UES) opening are still not fully understood. During swallowing, cricopharyngeal muscle relaxation is closely followed by anterior and superior hyo-laryngeal excursion which stretches open the UES. Pressure from the on-coming bolus further distends the UES to approximately 8mm, and then the UES closes all within 0.5 seconds ( Figure 1) (1, 2) . Inter-rater reliability of UES opening measures based on two-dimensional videofluoroscopy images is poor (3) .
Currently, there is no diagnostic method capable of objectively differentiating between each phase of UES opening. A better understanding of UES function could improve the rehabilitative or surgical treatment of aspiration and inefficient bolus clearance in individuals with dysphagia.
FIGURE 1 HERE
The functional lumen imaging probe (FLIP) is a novel distensibility evaluation technique based on the principles of impedance planimetry (4) .
FLIP was first used to evaluate esophogastric junction (EGJ) distensibility, and has since evaluated the upper esophagus, the sphincter of Oddi and laparoscopic lumens (4) (5) (6) (7) (8) . To date, no studies have investigated the role of FLIP in evaluating UES function. Videofluoroscopy studies have demonstrated safe insertion and distension of the FLIP balloon in the UES of patients with dysphagia ( Figure 2C ) (9) . The aims of this exploratory study were to use FLIP to (i) to derive preliminary data on UES distensibility and (ii) to measure UES diameter and intra-balloon pressure at rest, during swallowing and during voluntary manoeuvres previously described in a pilot group of healthy subjects (10) .
Methods

Subjects
Subjects were recruited from a pool of healthy volunteers. Inclusion criteria were (1) no history of oro-pharyngeal or oesophageal dysphagia, (2) no history of gastrointestinal, neurological or respiratory disease (3) no history of head and neck cancer or ear nose and throat conditions. Eleven healthy adults (three male), with a mean age of 34 years (range 20-50; standard deviation (SD) 11.3) met inclusion criteria. Written consent was obtained from subjects. Before each FLIP evaluation, all voluntary swallowing manoeuvres included in the assessment were explained and demonstrated to subjects. Ethical approval was obtained from the Research Ethics Committee, University Hospitals Leuven, Belgium.
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EndoFLIP ® System
A commercially developed FLIP (EndoFLIP ® system, Crospon Ltd., Galway, Ireland) was used ( Figure 2A) . A polyutherane balloon with a maximum volume of 60 ml was mounted on the distal 14 cm of a probe (EF-325) (length 240cm, diameter 25mm) attached to the EndoFLIP ® unit ( Figure   2B ). This balloon assumes a 10cm long cylindrical shape with maximum diameter of 2.5 cm. The maximum balloon diameter was critical to prevent airway compromise during balloon distension. Across an 7.5cm segment within the balloon, 17 ring electrodes were spaced 5mm apart to obtain 16 impedance planimetry measurements ( Figure 2B ). This allowed diameter and pressure changes above (i.e. pharynx) and below (i.e. upper esophagus) the UES to be captured and for UES opening to be observed despite its upward shift during swallowing. Excitation electrodes situated at either end of the 17 ring electrodes emitted a constant low electrical current within the balloon.
The probe also contained a solid-state pressure transducer to measure intraballoon pressure.
Protocol
The When the subject was accustomed to the probe, the probe balloon within the esophagus was distended with 10mls saline solution from the syringe using a touch screen function on the EndoFLIP ® monitor. The inflated balloon was slowly retracted until the hourglass shape of the UES could be visualised on the EndoFLIP ® screen (17-20cm marking on FLIP catheter) ( Figure 2D ). This confirmed the balloon position in the UES. While holding the catheter in place, the balloon was deflated by pressing the touch screen control on the unit monitor.
After a brief habituation period (1-2 minutes), two 20ml ramp distensions were completed (rate 60ml/minute). Subjects were requested not to swallow during distensions and the EndoFLIP ® screen was monitored to ensure the balloon remained in position. The balloon was re-inflated with either 12ml or 15mls conductive solution (balloon volume was reduced to 12mls after two studies to optimise tolerance). Once a baseline measure of minimum UES diameter (mm) and intra-balloon pressure (mmHg) was recorded, subjects were asked to complete the following: A minimum 10 second time period between the performances of each strategy was enforced to easily identify manoeuvres during data analysis.
The time (in seconds) displayed on the EndoFLIP ® device at the execution of each manoeuvre was recorded. When the protocol was completed, the balloon was deflated and the probe was removed.
Data Analysis
To evaluate UES distensibility, mean cross-sectional area and intraballoon pressure measures were determined at 5, 10, 15 and 20ml volumes.
Using times (in seconds) recorded from the EndoFLIP ® unit, measures of (i) minimum UES diameter (mm) and (ii) minimum intra-balloon pressure (mmHg) were attained at baseline, during dry and liquid swallowing and during voluntary manoeuvres. Descriptive statistics were used to analyse results.
Results
TABLE 1 HERE
Ten of eleven subjects completed the study protocol. Subject 2 did not complete the study due to intolerance of the distended balloon in the UES for a prolonged period. Subject 1 did not complete voluntary postures and manoeuvres during 5ml liquid swallows as it was only upon completion of this initial study that authors ascertained that liquid could be swallowed with the balloon distended in the UES and then extended the protocol for subsequent studies.
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During 20ml ramp distensions, the EndoFLIP ® balloon assumed an hourglass shape at the level of the UES across all subjects (Figure 3 ). Mean increases in intra-balloon pressure and cross-sectional area during ramp distensions are detailed in Table 1 . Figure   5 .
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Discussion
This preliminary study tested the use of FLIP to evaluate UES dynamics in a pilot group of healthy subjects. The FLIP balloon was positioned and distended in the UES without fluoroscopic guidance and studies were completed without incident or adverse event. While all subjects tolerated FLIP placement in the UES region, one of eleven subjects could not tolerate the inflated probe in the UES for prolonged periods to complete the study protocol. Further studies will need to be completed to establish tolerance levels.
During distensibility testing, ramp distensions were conducted to a lower maximum volume (20ml) than EGJ studies to ensure the airway was not impinged. Nevertheless, the hourglass shape of the UES could be observed across subjects (Figure 3 ) and mean intra-balloon pressure and UES CSA increased across 10, 15 and 20ml volumes ( Table 1) .
Maximum UES diameters during dry and liquid swallowing as measured by FLIP are similar to videofluoroscopy measures (2) (Figure 1 ). Albeit with varying balloon volumes (12 or 15mls), FLIP also established mean effects of voluntary manoeuvres on extent of UES opening ( Table 2 ). Effectiveness of strategies could be determined within evaluations due to real-time geometric profile of the UES on the EndoFLIP ® screen.
Of note, the minimal detectable diameter of the EndoFLIP probe is 4.8mm (or 18.1mm 2 ) because of its physical size. Therefore, if the probe measures 4.8mm the actual value may be smaller than that. This is a source of error which may make the deviation of data for these small measurements seem less than it actually is. Additionally, FLIP does not provide real 
Figure 5
Geometric Profiles of UES on EndoFLIP ® Screen Across Voluntary Manoeuvres in a Healthy Subject.
